Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 90-98

  Brown, K S ^a   Keogh, M J ^a   Tagiuri, N ^a   Grainge, M J ^a   Presanis, J S ^b   Ryder, S D ^c   Irving, W L ^a   Ball, J K ^a   Sim, R B ^b   Hickling, T P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Fibrogenesis; HCV; Innate immunity; Mannan binding lectin; Mannan binding lectin associated serine protease 1

Indexed keywords

ENZYME PRECURSOR; HEPATITIS C ANTIBODY; MANNAN BINDING LECTIN; MANNAN BINDING PROTEIN ASSOCIATED SERINE PROTEASE 1; PROTEINASE;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROGENESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; SEQUENTIAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); FATTY LIVER; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED;

EID: 33845473916     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03264.x     Document Type: Article

References (43)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepatol 1999; 6:35-47.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20:1-16.
3. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-9.
4. Knodell RG, Ishak KG, Black WC. et al. Formulation and application of a numerical scoring systemfor assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-5.
5. Kawasaki T. Structure and biology of mannan-binding protein, MBP, an important component of innate immunity. Biochim Biophys Acta 1999; 1473:186-95.
6. Wallis R, Cheng JY. Molecular defects in variant forms of mannose-binding protein associated with immunodeficiency. J Immunol 1999; 163:4953-9.
7. Larsen F, Madsen HO, Sim RB, Koch C, Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem 2004; 279:21302-11.
8. Arora M, Munoz E, Tenner AJ. Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis. J Biol Chem 2001; 276:43087-94.
9. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998; 161:3169-75.
10. Butler GS, Sim D, Tam E, Devine D, Overall CM. Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis: potential role in human MBL deficiency. J Biol Chem 2002; 277:17511-9.
11. Chong WP, To YF, Ip WK et al. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 2005; 42:1037-45.
12. Sasaki K, Tsutsumi A, Wakamiya N et al. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol 2000; 35:960-5.
13. Matsushita M, Hijikata M, Ohta Y et al. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 1998; 143:645-51.
14. Matsushita M, Hijikata M, Ohta Y, Mishiro S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol 1998; 29:695-700.
15. Kilpatrick DC, Delahooke TE, Koch C, Turner ML, Hayes PC. Mannan-binding lectin and hepatitis C infection. Clin Exp Immunol 2003; 132:92-5.
16. Dahl MR, Thiel S, Matsushita M et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001; 15:127-35.
17. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992; 176:1497-502.
18. Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386:506-10.
19. Stover CM, Thiel S, Thelen M et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 1999; 162:3481-90.
20. Ambrus G, Gal P, Kojima M et al. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J Immunol 2003; 170:1374-82.
21. Hajela K, Kojima M, Ambrus G et al. The biological functions of MBL-associated serine proteases (MASPs). Immunobiology 2002; 205:467-75.
22. Presanis JS, Hajela K, Ambrus G, Gal P, Sim RB. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol Immunol 2004; 40:921-9.
23. Corpechot C, Barbu V, Wendum D et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002; 35:1010-21.
24. Gaca MD, Zhou X, Benyon RC. Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. J Hepatol 2002; 36:362-9.
25. Mallat A, Gallois C, Tao J et al. Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. J Biol Chem 1998; 273:27300-5.
26. Marra F, DeFranco R, Grappone C et al. Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. Hepatology 1998; 27:462-71.
27. Marra F, Grandaliano G, Valente AJ, Abboud HE. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology 1995; 22:780-7.
28. Neubauer K, Knittel T, Armbrust T, Ramadori G. Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology 1995; 108:1124-35.
29. Bouwman LH, Roos A, Terpstra OT et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129:408-14.
30. Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol 1994; 6:665-9.
31. Mohsen AH, Group TH. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001; 48:707-13.
32. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC. Progression of hepatic fibrosis in patients with hepatitis C. a prospective repeat liver biopsy study. Gut 2004; 53:451-5.
33. Arnold JN, Radcliffe CM, Wormald MR et al. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol 2004; 173:6831-40.
34. Datz C, Cramp M, Haas T et al. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 1999; 44:563-7.
35. Su AI, Pezacki JP, Wodicka L et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002; 99:15669-74.
36. Bigger CB, Guerra B, Brasky KM et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004; 78:13779-92.
37. Mayilyan KR, Presanis JS, Arnold JN, Hajela K, Sim RB. Heterogeneity of MBL MASP complexes. Mol Immunol 2006; 43:1286-92.
38. Papatheodoridis GV, Papakonstantinou E, Andrioti E et al. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 2003; 52:404-9.
39. Wright M, Goldin R, Hellier S et al. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 2003; 52:1206-10.
40. Dunn DL, Simmons RL. Fibrin in peritonitis. III. The mechanism of bacterial trapping by polymerizing fibrin. Surgery 1982; 92:513-9.
41. Hurst TJ, Wilton JM. Phagocytosis of Porphyromonas gingivalis and Prevotella intermedia by human polymorphonuclear leukocytes in clots formed from human plasma or purified fibrinogen. J Periodontal Res 1992; 27:111-18.
42. Szaba FM, Smiley ST. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 2002; 99:1053-9.
43. Senior RM, Skogen WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 1986; 77:1014-19.